サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1401950

神経刺激の2030年までの市場予測： タイプ別、用途別、地域別の世界分析

Neurostimulation Market Forecasts to 2030 - Global Analysis By Type, Application and By Geography
出版日: | 発行: Stratistics Market Research Consulting | ページ情報: 英文 200+ Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.49円
神経刺激の2030年までの市場予測： タイプ別、用途別、地域別の世界分析
出版日: 2023年12月01日
発行: Stratistics Market Research Consulting
ページ情報: 英文 200+ Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Stratistics MRCによると、神経刺激の世界市場は2023年に62億2,120万米ドルを占め、2030年には133億2,900万米ドルに達すると予測され、予測期間中のCAGRは11.5％です。

調整された電気的または磁気的インパルスを使用して神経系の活動を変化させることは、神経刺激として知られています。これは、精神疾患、運動障害、慢性疼痛など、さまざまな神経障害の治療に用いられます。さらに、神経刺激は神経回路を調整し、関連する症状を緩和する可逆的でカスタマイズ可能な方法であり、現在も新たな応用法の研究や既存技術の最適化が進められています。

米国疾病予防管理センター（CDC）によると、北米では慢性腰痛の治療に毎年推定500億米ドルが費やされています。

非侵襲的代替手段の増加

非侵襲的な神経刺激法の開発と、経頭蓋磁気刺激（TMS）や経皮的電気神経刺激（TENS）のような非外科的アプローチを提供する技術の進歩の結果として受け入れられつつあるこれらの方法は、患者の消極性を軽減し、市場範囲を拡大しています。このシフトは患者の快適性と安全性を向上させるだけでなく、効率的で手頃な価格の低侵襲ソリューションを提供し、神経刺激療法の方向性を左右する重要な役割を果たす立場にあり、市場規模を押し上げています。

高コスト

神経刺激装置の開発、製造、販売は、高度な技術、多くの調査、規制の遵守を必要とする高価なプロセスです。特殊な部品、最先端の素材、複雑な製造技術など、すべてが高額な費用の原因となっています。購入しやすい価格と償還という点で、こうした法外なコストは患者やヘルスケアプロバイダーに困難をもたらします。そのため、高額な自己負担費用と保険適用の欠如が神経刺激市場の妨げになる可能性があります。

技術的進歩

技術革新は、神経刺激治療の精度、有効性、安全性を向上させる電極技術、プログラミング機能、機器設計などの絶え間ない革新により、閉ループまたは適応型神経刺激システムの開発を促進してきました。さらに、無線通信技術の統合により、より優れた患者モニタリングと神経刺激パラメータのリアルタイム調整が可能になります。患者の転帰を改善し、アンメットメディカルニーズに対応することが、神経刺激療法市場を全体的に後押ししています。

副作用

神経刺激はすべての神経症状に同じように有効であるとは限らず、侵襲的な処置や植え込み型機器に固有のリスク（感染、機器の誤作動、予期せぬ副作用など）により、患者の安全性や信頼性に影響を及ぼします。さらに、有害事象は、市場での製品の評判を傷つけ、規制上の懸念や法的問題を生じさせ、その普及を妨げる可能性があります。その結果、神経刺激市場の妨げとなります。

COVID-19の影響

COVID-19の流行は神経刺激市場に悪影響を及ぼし、製造、サプライチェーン、選択的医療処置に混乱をもたらしました。不要不急のヘルスケアサービスの制限、患者の受診抑制、医療資源の転用により、神経刺激装置の移植が遅れ、患者へのアクセスが低下しています。経済の不確実性も投資や研究資金に影響を与えています。したがって、これらの要因は市場の拡大を大きく阻害しています。

迷走神経刺激装置セグメントは予測期間中最大になる見込み

迷走神経刺激装置セグメントが最大のシェアを占めると推定されます。これらの埋め込み型デバイスは迷走神経を刺激し、脳に電気インパルスを送ることで作動します。技術の進歩、デバイスの小型化、神経生理学の理解向上などが、認知度に寄与するイノベーションの一部です。非薬物療法の選択肢に対する需要と神経疾患の有病率の増加が、神経刺激市場におけるVNS分野の拡大に寄与しています。

パーキンソン病分野は予測期間中に最も高いCAGRが見込まれる

パーキンソン病分野は、植え込み型デバイスの使用による症状の軽減により、予測期間中のCAGRが最も高くなると予測されています。パーキンソン病に対する神経刺激は脳深部刺激療法（DBS）と呼ばれ、特定の脳領域に電極を埋め込み、異常な神経活動を修正します。DBSによって患者のQOLは改善し、薬物依存は減少し、運動症状は軽減します。したがって、DBSは神経刺激技術の開発と進歩にも大きく寄与しており、この分野の拡大を後押ししています。

最大のシェアを占める地域

アジア太平洋地域は、ヘルスケアインフラ、償還政策、規制の枠組みが評価され、予測期間中に最大の市場シェアを占めました。高齢化とそれに伴う神経変性疾患の増加が、神経刺激療法の需要拡大に寄与しています。この地域には、Boston Scientific Corporation、Abbott Laboratories、Medtronic plc、Neuronetics, Inc.などの主要企業が進出しています。同地域の融資・償還政策と新技術が市場規模を牽引しています。

CAGRが最も高い地域：

予測期間中、欧州のCAGRが最も高いと予想されます。規制機関や各国の保健当局は、神経刺激装置の承認と規制において重要な役割を果たしています。治療効果や患者の転帰における進歩には、強化された電極設計、正確なターゲティング、高度なプログラミング機能などが含まれます。ドイツ、英国、フランスなどの欧州諸国も、神経障害に対する最先端技術の導入に大きく貢献しており、この地域の成長を牽引しています。

無料カスタマイズサービス：

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

  • 企業プロファイル
    • 追加市場プレイヤーの包括的プロファイリング（3社まで）
    • 主要企業のSWOT分析（3社まで）
  • 地域セグメンテーション
    • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
  • 競合ベンチマーキング
    • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

  • 概要
  • ステークホルダー
  • 調査範囲
  • 調査手法
    • データマイニング
    • データ分析
    • データ検証
    • 調査アプローチ
  • 調査ソース
    • 1次調査ソース
    • 2次調査ソース
    • 前提条件

第3章 市場動向分析

  • 促進要因
  • 抑制要因
  • 機会
  • 脅威
  • 用途分析
  • 新興市場
  • 新型コロナウイルス感染症（COVID-19）の影響

第4章 ポーターのファイブフォース分析

  • 供給企業の交渉力
  • 買い手の交渉力
  • 代替品の脅威
  • 新規参入業者の脅威
  • 競争企業間の敵対関係

第5章 世界の神経刺激市場：タイプ別

  • 仙骨神経刺激装置
  • 脊髄刺激装置
  • 迷走神経刺激装置
  • 脳深部刺激装置
  • その他のタイプ

第6章 世界の神経刺激市場：用途別

  • 難聴
  • 尿失禁
  • 疼痛管理
  • てんかん
  • パーキンソン病
  • その他の用途

第7章 世界の神経刺激市場：地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • イタリア
    • フランス
    • スペイン
    • その他欧州
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • オーストラリア
    • ニュージーランド
    • 韓国
    • その他アジア太平洋地域
  • 南米
    • アルゼンチン
    • ブラジル
    • チリ
    • その他南米
  • 中東とアフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • カタール
    • 南アフリカ
    • その他中東とアフリカ

第8章 主な発展

  • 契約、パートナーシップ、コラボレーション、合弁事業
  • 買収と合併
  • 新製品の発売
  • 事業拡大
  • その他の主要戦略

第9章 企業プロファイル

  • Medtronic
  • LivaNova PLC
  • Abbott
  • Neuronetics
  • Boston Scientific Corporation
  • Nevro Corp
  • LABORIE
  • Johnson & Johnson Services
  • NeuroPace, Inc.
  • Synapse Biomedical Inc
  • NeuroSigma, Inc
  • Modulus, Inc
  • Biegler GmbH
図表

List of Tables

  • Table 1 Global Neurostimulation Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Neurostimulation Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Neurostimulation Market Outlook, By Sacral Nerve Stimulators (2021-2030) ($MN)
  • Table 4 Global Neurostimulation Market Outlook, By Spinal Cord Stimulators (2021-2030) ($MN)
  • Table 5 Global Neurostimulation Market Outlook, By Vagus Nerve Stimulators (2021-2030) ($MN)
  • Table 6 Global Neurostimulation Market Outlook, By Deep Brain Stimulators (2021-2030) ($MN)
  • Table 7 Global Neurostimulation Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 8 Global Neurostimulation Market Outlook, By Application (2021-2030) ($MN)
  • Table 9 Global Neurostimulation Market Outlook, By Hearing Loss (2021-2030) ($MN)
  • Table 10 Global Neurostimulation Market Outlook, By Urinary Incontinence (2021-2030) ($MN)
  • Table 11 Global Neurostimulation Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 12 Global Neurostimulation Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 13 Global Neurostimulation Market Outlook, By Parkinson's disease (2021-2030) ($MN)
  • Table 14 Global Neurostimulation Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 15 North America Neurostimulation Market Outlook, By Country (2021-2030) ($MN)
  • Table 16 North America Neurostimulation Market Outlook, By Type (2021-2030) ($MN)
  • Table 17 North America Neurostimulation Market Outlook, By Sacral Nerve Stimulators (2021-2030) ($MN)
  • Table 18 North America Neurostimulation Market Outlook, By Spinal Cord Stimulators (2021-2030) ($MN)
  • Table 19 North America Neurostimulation Market Outlook, By Vagus Nerve Stimulators (2021-2030) ($MN)
  • Table 20 North America Neurostimulation Market Outlook, By Deep Brain Stimulators (2021-2030) ($MN)
  • Table 21 North America Neurostimulation Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 22 North America Neurostimulation Market Outlook, By Application (2021-2030) ($MN)
  • Table 23 North America Neurostimulation Market Outlook, By Hearing Loss (2021-2030) ($MN)
  • Table 24 North America Neurostimulation Market Outlook, By Urinary Incontinence (2021-2030) ($MN)
  • Table 25 North America Neurostimulation Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 26 North America Neurostimulation Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 27 North America Neurostimulation Market Outlook, By Parkinson's disease (2021-2030) ($MN)
  • Table 28 North America Neurostimulation Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 29 Europe Neurostimulation Market Outlook, By Country (2021-2030) ($MN)
  • Table 30 Europe Neurostimulation Market Outlook, By Type (2021-2030) ($MN)
  • Table 31 Europe Neurostimulation Market Outlook, By Sacral Nerve Stimulators (2021-2030) ($MN)
  • Table 32 Europe Neurostimulation Market Outlook, By Spinal Cord Stimulators (2021-2030) ($MN)
  • Table 33 Europe Neurostimulation Market Outlook, By Vagus Nerve Stimulators (2021-2030) ($MN)
  • Table 34 Europe Neurostimulation Market Outlook, By Deep Brain Stimulators (2021-2030) ($MN)
  • Table 35 Europe Neurostimulation Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 36 Europe Neurostimulation Market Outlook, By Application (2021-2030) ($MN)
  • Table 37 Europe Neurostimulation Market Outlook, By Hearing Loss (2021-2030) ($MN)
  • Table 38 Europe Neurostimulation Market Outlook, By Urinary Incontinence (2021-2030) ($MN)
  • Table 39 Europe Neurostimulation Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 40 Europe Neurostimulation Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 41 Europe Neurostimulation Market Outlook, By Parkinson's disease (2021-2030) ($MN)
  • Table 42 Europe Neurostimulation Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 43 Asia Pacific Neurostimulation Market Outlook, By Country (2021-2030) ($MN)
  • Table 44 Asia Pacific Neurostimulation Market Outlook, By Type (2021-2030) ($MN)
  • Table 45 Asia Pacific Neurostimulation Market Outlook, By Sacral Nerve Stimulators (2021-2030) ($MN)
  • Table 46 Asia Pacific Neurostimulation Market Outlook, By Spinal Cord Stimulators (2021-2030) ($MN)
  • Table 47 Asia Pacific Neurostimulation Market Outlook, By Vagus Nerve Stimulators (2021-2030) ($MN)
  • Table 48 Asia Pacific Neurostimulation Market Outlook, By Deep Brain Stimulators (2021-2030) ($MN)
  • Table 49 Asia Pacific Neurostimulation Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 50 Asia Pacific Neurostimulation Market Outlook, By Application (2021-2030) ($MN)
  • Table 51 Asia Pacific Neurostimulation Market Outlook, By Hearing Loss (2021-2030) ($MN)
  • Table 52 Asia Pacific Neurostimulation Market Outlook, By Urinary Incontinence (2021-2030) ($MN)
  • Table 53 Asia Pacific Neurostimulation Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 54 Asia Pacific Neurostimulation Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 55 Asia Pacific Neurostimulation Market Outlook, By Parkinson's disease (2021-2030) ($MN)
  • Table 56 Asia Pacific Neurostimulation Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 57 South America Neurostimulation Market Outlook, By Country (2021-2030) ($MN)
  • Table 58 South America Neurostimulation Market Outlook, By Type (2021-2030) ($MN)
  • Table 59 South America Neurostimulation Market Outlook, By Sacral Nerve Stimulators (2021-2030) ($MN)
  • Table 60 South America Neurostimulation Market Outlook, By Spinal Cord Stimulators (2021-2030) ($MN)
  • Table 61 South America Neurostimulation Market Outlook, By Vagus Nerve Stimulators (2021-2030) ($MN)
  • Table 62 South America Neurostimulation Market Outlook, By Deep Brain Stimulators (2021-2030) ($MN)
  • Table 63 South America Neurostimulation Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 64 South America Neurostimulation Market Outlook, By Application (2021-2030) ($MN)
  • Table 65 South America Neurostimulation Market Outlook, By Hearing Loss (2021-2030) ($MN)
  • Table 66 South America Neurostimulation Market Outlook, By Urinary Incontinence (2021-2030) ($MN)
  • Table 67 South America Neurostimulation Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 68 South America Neurostimulation Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 69 South America Neurostimulation Market Outlook, By Parkinson's disease (2021-2030) ($MN)
  • Table 70 South America Neurostimulation Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 71 Middle East & Africa Neurostimulation Market Outlook, By Country (2021-2030) ($MN)
  • Table 72 Middle East & Africa Neurostimulation Market Outlook, By Type (2021-2030) ($MN)
  • Table 73 Middle East & Africa Neurostimulation Market Outlook, By Sacral Nerve Stimulators (2021-2030) ($MN)
  • Table 74 Middle East & Africa Neurostimulation Market Outlook, By Spinal Cord Stimulators (2021-2030) ($MN)
  • Table 75 Middle East & Africa Neurostimulation Market Outlook, By Vagus Nerve Stimulators (2021-2030) ($MN)
  • Table 76 Middle East & Africa Neurostimulation Market Outlook, By Deep Brain Stimulators (2021-2030) ($MN)
  • Table 77 Middle East & Africa Neurostimulation Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 78 Middle East & Africa Neurostimulation Market Outlook, By Application (2021-2030) ($MN)
  • Table 79 Middle East & Africa Neurostimulation Market Outlook, By Hearing Loss (2021-2030) ($MN)
  • Table 80 Middle East & Africa Neurostimulation Market Outlook, By Urinary Incontinence (2021-2030) ($MN)
  • Table 81 Middle East & Africa Neurostimulation Market Outlook, By Pain Management (2021-2030) ($MN)
  • Table 82 Middle East & Africa Neurostimulation Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 83 Middle East & Africa Neurostimulation Market Outlook, By Parkinson's disease (2021-2030) ($MN)
  • Table 84 Middle East & Africa Neurostimulation Market Outlook, By Other Applications (2021-2030) ($MN)
目次
Product Code: SMRC24470

According to Stratistics MRC, the Global Neurostimulation Market is accounted for $6,221.2 million in 2023 and is expected to reach $13,329.0 million by 2030 growing at a CAGR of 11.5% during the forecast period. The use of regulated electrical or magnetic impulses to alter the nervous system's activity is known as neurostimulation. It is used to treat various neurological disorders such as psychiatric disorders, movement disorders, and chronic pain. Furthermore, neurostimulation is a potentially reversible and customizable method of modulating neural circuitry and relieving symptoms associated, with ongoing research exploring new applications and optimizing existing technologies.

According to Centers for Disease Control and Prevention (CDC), an estimated USD 50 billion are spent each year for treatment of chronic lower back pain in North America.

Market Dynamics:

Driver:

Increase in non-invasive alternatives

The development of non-invasive neurostimulation methods and their increasing acceptance as a result of technological advancements like transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS) which offer non-surgical approaches, reducing patient reluctance and expanding the market reach. This shift not only improve patient comfort and safety but also provide efficient, affordable, and minimally invasive solutions which place them in a position to play a significant role in influencing the direction of neurostimulation therapy, which are driving the market size.

Restraint:

High cost

Neurostimulation device development, manufacture, and distribution are expensive processes that require sophisticated technology, a great deal of research, and adherence to regulations. Specialized parts, cutting-edge materials, and complex manufacturing techniques all contribute to the higher expenses. In terms of affordability and reimbursement, these exorbitant cost present difficulties for patients and healthcare providers. Therefore, high out-of-pocket costs and a lack of insurance coverage may impede neurostimulation market.

Opportunity:

Technological advancements

Technological innovations have facilitated the development of closed-loop or adaptive neurostimulation systems with constant innovations including electrode technologies, programming capabilities, and device design which improves the accuracy, effectiveness, and safety of neurostimulation treatments. In addition, integration of wireless communication technologies enables better patient monitoring and real-time adjustments to neurostimulation parameters. By improving patient outcomes and addressing unmet medical needs overall propels the neurostimulation market.

Threat:

Side effects

Neurostimulation may not be equally effective for all neurological conditions which effects patient safety and confidence by the inherent risks associated with invasive procedures and implantable devices, which include infection, malfunctioning of the device, and unintended side effects. Moreover, adverse events can damage a product's reputation in the market and prevent its widespread adoption by giving rise to regulatory worries and legal issues. Thus, consequently hinder the neurostimulation market.

COVID-19 Impact

The COVID-19 pandemic has negatively impacted the neurostimulation market, causing disruptions in manufacturing, supply chains, and elective medical procedures. Restrictions on non-essential healthcare services, reduced patient visits, and diverted healthcare resources have led to delays in neurostimulation device implantations and decreased patient access. Economic uncertainties have also affected investment and research funding. Therefore, these factors significantly impede market expansion.

The vagus nerve stimulators segment is expected to be the largest during the forecast period

The vagus nerve stimulators segment is estimated to hold the largest share. These implantable devices stimulate the vagus nerve, which operates by sending electrical impulses to the brain. Technological advancements, miniaturization of devices, and improved understanding of neurophysiology are some of the innovations contributing awareness. The demand for non-pharmacological treatment options and the increasing prevalence of neurological disorders contribute to the expansion of the VNS segment in the Neurostimulation market.

The parkinson's disease segment is expected to have the highest CAGR during the forecast period

The parkinson's disease segment is anticipated to have the highest CAGR during the forecast period due to reducing symptoms by using implantable devices. Neurostimulation for Parkinson's disease is called deep brain stimulation (DBS), which involves implanting electrodes in particular brain areas to modify aberrant neural activity. The patients' quality of life is improved, medication dependence is decreased, and motor symptoms are reduced with DBS. Hence, it also makes a substantial contribution to the development and advancement of neurostimulation technologies which are propelling this segment expansion.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to evaluations of the healthcare infrastructure, reimbursement policies, and regulatory frameworks. The aging population and the subsequent increase in neurodegenerative diseases contribute to the expanding demand for neurostimulation therapies. The region is home to major key players such as Boston Scientific Corporation, Abbott Laboratories, Medtronic plc and Neuronetics, Inc. The region's financing and reimbursement policies and new technologies is driving the market size.

Region with highest CAGR:

Europe is expected to witness highest CAGR over the projection period. Regulatory bodies and national health authorities play a crucial role in approving and regulating neurostimulation devices. Advancements in treatment efficacy and patient outcomes include enhanced electrode designs, precise targeting, and advanced programming capabilities. Countries within Europe, including Germany, the United Kingdom, France, and others, also contribute significantly to the adoption of cutting-edge technologies for neurological disorders which thereby driving region growth.

Key players in the market:

Some of the key players in the Neurostimulation Market include Medtronic, LivaNa PLC, Abbott, Neuronetics, Boston Scientific Corporation, Nevro Corp, Laborie, Johnson & Johnson Services, NeuroPace, Inc., Synapse Biomedical Inc, NeuroSigma, Inc, Modulus, Inc and Biegler GmbH.

Key Developments:

In October 2023, Boston Scientific Corporation announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication of the WaveWriter Alpha™ Spinal Cord Stimulator (SCS) Systems for the treatment of painful diabetic peripheral neuropathy (DPN), a complication of diabetes that can affect the lower extremities of the body.

In September 2023, Abbott announced it has completed the acquisition of Bigfoot Biomedical, a leader in developing smart insulin management systems for people with diabetes.

In August 2023, Medtronic announced the outcome of the U.S. Food & Drug Administration (FDA) Circulatory System Devices Panel (CSDP) meeting to review data presented in support of the Medtronic Symplicity Spyral™ Renal Denervation (RDN) System.

In June 2023, the American Diabetes Association® (ADA) and Abbott announced a collaboration aimed at better understanding how diabetes technology like continuous glucose monitoring (CGM) systems can help people living with diabetes make informed decisions about their food and activity.

Types Covered:

  • Sacral Nerve Stimulators
  • Spinal Cord Stimulators
  • Vagus Nerve Stimulators
  • Deep Brain Stimulators
  • Other Types

Applications Covered:

  • Hearing Loss
  • Urinary Incontinence
  • Pain Management
  • Epilepsy
  • Parkinson's disease
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neurostimulation Market, By Type

  • 5.1 Introduction
  • 5.2 Sacral Nerve Stimulators
  • 5.3 Spinal Cord Stimulators
  • 5.4 Vagus Nerve Stimulators
  • 5.5 Deep Brain Stimulators
  • 5.6 Other Types

6 Global Neurostimulation Market, By Application

  • 6.1 Introduction
  • 6.2 Hearing Loss
  • 6.3 Urinary Incontinence
  • 6.4 Pain Management
  • 6.5 Epilepsy
  • 6.6 Parkinson's disease
  • 6.7 Other Applications

7 Global Neurostimulation Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Medtronic
  • 9.2 LivaNova PLC
  • 9.3 Abbott
  • 9.4 Neuronetics
  • 9.5 Boston Scientific Corporation
  • 9.6 Nevro Corp
  • 9.7 LABORIE
  • 9.8 Johnson & Johnson Services
  • 9.9 NeuroPace, Inc.
  • 9.10 Synapse Biomedical Inc
  • 9.11 NeuroSigma, Inc
  • 9.12 Modulus, Inc
  • 9.13 Biegler GmbH